AMIACT is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species, Escherichia coli, species of indole-positive and indole-negative Proteus, Providencia species, Klebsiella-Enterobacter-Serratia species, and Acinetobacter (formerly Mima-Herellea) species and Citrobacter freundii.

AZIKEN is indicated in the treatment of:

• Upper respiratory tract infections (including ear, nose and throat infections): Tonsillitis, sinusitis, otitis media and pharyngitis.
• Lower respiratory tract infections: Community acquired pneumonias, acute bacterial exacerbations of chronic bronchitis, chronic obstructive pulmonary disease, bronchitis due to Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae.
• Genitourinary tract infections (including sexually transmitted diseases): Urethritis, prostatitis, cervicitis, cervico-vaginitis and salpingitis due to N. gonorrhoeae and C. trachomatis. Genital ulcer disease (chanchroid) in men due to Haemophilus ducreyi.
• Skin and skin structure infections: Folliculitis, furuncles, carbuncles, impetigo, pyoderma, infected ulcer, infected dermatitis, cellulitis and erysipelas due to S. aureus, S. pyogenes or S. agalactiae.

CEFSUL is mainly indicated in the following conditions:

• Lower respiratory tract infections and community acquired pneumonia
• Acute bacterial otitis media
• Skin and skin structure infections
• Urinary tract infections
• Uncomplicated gonorrhea
• Pelvic inflammatory disease
• Bacterial septicemia
• Bone and joint infections
• Intra-abdominal infections
• Bacterial meningitis

MERON is indicated for treatment, in adults and children, of the following infections caused by single or multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms:

• Lower Respiratory Tract Infections

• Urinary Tract Infections, including complicated infections

• Intra-abdominal Infections

• Gynaecological Infections, including postpartum infections

• Skin and Skin Structure Infections

• Meningitis

• Septicaemia

• Empiric treatment, including initital monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients

Infections caused by pathogens sensitive to ceftriaxone such as

Sepsis

meningitis in neonates and infants

perioperative prophylaxis of infections

renal and urinary tract infections

respiratory tract infections, particularly pneumonia, and ear, nose and throat infections.

infections of the bones, joints, soft tissue, skin and of wounds.

abdominal infections (peritonitis, infections of the biliary tract).

uncomplicated gonorrhea

Cefixime is indicated in the treatment of the following infections

• Typhoid fever
• Uncomplicated Urinary Tract Infections
• Otitis Media
• Pharyngitis and Tonsillitis,
• Acute Bronchitis and Acute Exacerbations of Chronic Bronchitis
• Uncomplicated gonorrhea